176 related articles for article (PubMed ID: 28625628)
21. Prognostic factor analysis of patients with small cell lung cancer: Real-world data from 988 patients.
Ma X; Zhang Z; Chen X; Zhang J; Nie J; Da L; Hu W; Tian G; Wu D; Han J; Han S; Long J; Wang Y; Fang J
Thorac Cancer; 2021 Jun; 12(12):1841-1850. PubMed ID: 33955685
[TBL] [Abstract][Full Text] [Related]
22. Omitting elective nodal irradiation and irradiating postinduction versus preinduction chemotherapy tumor extent for limited-stage small cell lung cancer: interim analysis of a prospective randomized noninferiority trial.
Hu X; Bao Y; Zhang L; Guo Y; Chen YY; Li KX; Wang WH; Liu Y; He H; Chen M
Cancer; 2012 Jan; 118(1):278-87. PubMed ID: 21598237
[TBL] [Abstract][Full Text] [Related]
23. Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer.
Grønberg BH; Halvorsen TO; Fløtten Ø; Brustugun OT; Brunsvig PF; Aasebø U; Bremnes RM; Tollåli T; Hornslien K; Aksnessæther BY; Liaaen ED; Sundstrøm S;
Acta Oncol; 2016 May; 55(5):591-7. PubMed ID: 26494411
[TBL] [Abstract][Full Text] [Related]
24. The role of postoperative radiotherapy (PORT) in combined small cell lung cancer (C-SCLC).
Men Y; Luo Y; Zhai Y; Liang J; Feng Q; Chen D; Xiao Z; Zhou Z; Hui Z; Wang L
Oncotarget; 2017 Jul; 8(30):48922-48929. PubMed ID: 28430661
[TBL] [Abstract][Full Text] [Related]
25. [Advances in thoracic consolidation radiotherapy after first-line immunotherapy combined with chemotherapy for extensive stage small cell lung cancer].
Zhao W; Wang L; Xie ZL; Song YN; Meng X; Li JS
Zhonghua Zhong Liu Za Zhi; 2024 Jun; 46(6):526-535. PubMed ID: 38880734
[TBL] [Abstract][Full Text] [Related]
26. Timing of thoracic radiotherapy in the treatment of extensive-stage small-cell lung cancer: important or not?
Luo J; Xu L; Zhao L; Cao Y; Pang Q; Wang J; Yuan Z; Wang P
Radiat Oncol; 2017 Feb; 12(1):42. PubMed ID: 28245874
[TBL] [Abstract][Full Text] [Related]
27. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial.
Slotman BJ; van Tinteren H; Praag JO; Knegjens JL; El Sharouni SY; Hatton M; Keijser A; Faivre-Finn C; Senan S
Lancet; 2015 Jan; 385(9962):36-42. PubMed ID: 25230595
[TBL] [Abstract][Full Text] [Related]
28. Guideline for the Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-line Chemotherapy.
Sun A; Durocher-Allen LD; Ellis PM; Ung YC; Goffin JR; Ramchandar K; Darling G
Clin Oncol (R Coll Radiol); 2018 Oct; 30(10):658-666. PubMed ID: 30007803
[TBL] [Abstract][Full Text] [Related]
29. Current patterns of care for patients with extensive stage small cell lung cancer: Survey of US radiation oncologists on their recommendations regarding thoracic consolidation radiotherapy.
Mitin T; Jain A; Degnin C; Chen Y; Henderson M; Thomas CR
Lung Cancer; 2016 Oct; 100():85-89. PubMed ID: 27597285
[TBL] [Abstract][Full Text] [Related]
30. A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial.
Morabito A; Daniele G; Costanzo R; Favaretto AG; Filipazzi V; Rossi A; Gebbia V; Castiglione F; Cavanna L; Maiello E; Sandomenico C; Bonanno L; Piazza E; Maione P; Piccirillo MC; Di Maio M; Rocco G; Gallo C; Perrone F; Gridelli C
Lung Cancer; 2017 Jun; 108():15-21. PubMed ID: 28625627
[TBL] [Abstract][Full Text] [Related]
31. Association of Chemoradiotherapy With Outcomes Among Patients With Stage I to II vs Stage III Small Cell Lung Cancer: Secondary Analysis of a Randomized Clinical Trial.
Salem A; Mistry H; Hatton M; Locke I; Monnet I; Blackhall F; Faivre-Finn C
JAMA Oncol; 2019 Mar; 5(3):e185335. PubMed ID: 30520977
[TBL] [Abstract][Full Text] [Related]
32. High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial.
Grønberg BH; Killingberg KT; Fløtten Ø; Brustugun OT; Hornslien K; Madebo T; Langer SW; Schytte T; Nyman J; Risum S; Tsakonas G; Engleson J; Halvorsen TO
Lancet Oncol; 2021 Mar; 22(3):321-331. PubMed ID: 33662285
[TBL] [Abstract][Full Text] [Related]
33. Selection of candidates for surgery as local therapy among early-stage small cell lung cancer patients: a population-based analysis.
Jin K; Zhang K; Zhou F; Dai J; Zhang P; Jiang G
Cancer Commun (Lond); 2018 Mar; 38(1):5. PubMed ID: 29764484
[TBL] [Abstract][Full Text] [Related]
34. Management of small-cell lung cancer: incremental changes but hope for the future.
Hann CL; Rudin CM
Oncology (Williston Park); 2008 Nov; 22(13):1486-92. PubMed ID: 19133604
[TBL] [Abstract][Full Text] [Related]
35. Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive-stage small cell lung cancer (ES-SCLC): Study protocol.
Deng L; Shayan G; Jiang W; Bi N; Wang L
Thorac Cancer; 2024 Apr; 15(11):938-943. PubMed ID: 38426233
[TBL] [Abstract][Full Text] [Related]
36. Thoracic radiation therapy could give survival benefit to elderly patients with extensive-stage small-cell lung cancer.
An C; Jing W; Zhang Y; Liu S; Wang H; Zhu K; Kong L; Guo H; Zhu H
Future Oncol; 2017 Jun; 13(13):1149-1158. PubMed ID: 28326834
[TBL] [Abstract][Full Text] [Related]
37. Impact of baseline characteristics on extensive-stage SCLC patients treated with etoposide/carboplatin: A secondary analysis of a phase III study.
Abdel-Rahman O
Clin Respir J; 2018 Oct; 12(10):2519-2524. PubMed ID: 30073795
[TBL] [Abstract][Full Text] [Related]
38. Surgery for limited-stage small-cell lung cancer.
Barnes H; See K; Barnett S; Manser R
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011917. PubMed ID: 28429473
[TBL] [Abstract][Full Text] [Related]
39. Consolidation radiotherapy for patients with extended disease small cell lung cancer in a single tertiary institution: impact of dose and perspectives in the era of immunotherapy.
Stanic K; Vrankar M; But-Hadzic J
Radiol Oncol; 2020 Jul; 54(3):353-363. PubMed ID: 32726294
[TBL] [Abstract][Full Text] [Related]
40. Prospective Single-Arm Phase 1 and 2 Study: Ipilimumab and Nivolumab With Thoracic Radiation Therapy After Platinum Chemotherapy in Extensive-Stage Small Cell Lung Cancer.
Perez BA; Kim S; Wang M; Karimi AM; Powell C; Li J; Dilling TJ; Chiappori A; Latifi K; Rose T; Lannon A; MacMillan G; Saller J; Grass GD; Rosenberg S; Gray J; Haura E; Creelan B; Tanvetyanon T; Saltos A; Shafique M; Boyle TA; Schell MJ; Conejo-Garcia JR; Antonia SJ
Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):425-435. PubMed ID: 33002543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
